Unconventional Treatment for an Unusual Cauda Equina Syndrome Associated with Nontuberculous Mycobacteria after Allogenic Stem Cell Transplantation in a Child with Acute Lymphoblastic Leukemia

Xinyu Li,Han Chen,Xia‐Wei Han,Xiujuan Peng,Dongfang Li,Dao-bin Zhou,Lü-Hong Xu,Jian‐Pei Fang,Ke Huang

DOI: https://doi.org/10.1002/pbc.29977

2022-01-01

Pediatric Blood & Cancer

Abstract:To the Editor, Nontuberculous mycobacteria (NTM) are increasingly recognized as opportunistic pathogens in immunocompromised hosts.1 Extrapulmonary infections, local, disseminated, or catheter-related,2 have been documented.1 One of the most dangerous infections is NTM meningitis.3,4 Though rare, it often results in a poor prognosis,5 with complicated management. There are various pathways for NTM meningitis, including ventriculoperitoneal shunt, trauma, contamination during surgery,6 communication with an infected focus,6 neoplasm,7 and systemicNTM infection.5–8 Herein, we report a case of cauda equina syndrome, caused byNTMabscess during themyeloablative allogenic stem cell transplantation (alloSCT) for acute lymphoblastic leukemia (ALL) complicated with central nervous system leukemia (CNSL). To the best of our knowledge, this is the first report of NTM meningitis after radiotherapy and led to cauda equina syndromeduring myeloablative alloSCT. A 13-year-old female was diagnosed with very high-risk B-ALL according to the NCCN recommendation.9 After induction of BerlinFrankfurt-Mĺunster (BFM) back bone chemotherapy, the patient grew a feverish accompanied with a positive NTM reading in blood culture. During consolidation therapy, shewas diagnosedwith CNSL. Brain and spinal cord magnetic resonance imaging (MRI) and chest computed tomography found no lesion before radiotherapy and alloSCT. Prior to alloSCT, a total dose of 18 Gy radiotherapy was performed. At the end of radiotherapy, the patient presented the following symptoms: fever, headache, blurred vision, vomiting, irritability, andweakness.We identified theNTM in the cerebrospinal fluid (CSF) culture. The diagnosis was later confirmed byMycobacterium abscessus specific 16S rRNA gene sequencing. The mean inhibitory concentrations (MIC) for this bacterium are provided in Table 1. We started an initial therapy of oral clarithromycin, amikacin combined with meropenem. Intrathecal injection of amikacin (30 mg) and dexamethasone (5 mg) was given weekly for four times to control the central nervous system (CNS) lesion. Central line was replaced before alloSCT. During myeloablative alloSCT, the above antibiotic therapy continued. Cyclosporine A (CsA) was given for graft versus host disease (GVHD) prophylaxis. One week after transplantation, the patient developed a persistent fever, with NTM positive in the CSF. Neoplasm in CSF was negative. The symptoms of cauda equina syndrome TABLE 1 Minimum inhibitory concentration (MIC) drug sensitivity of the identified nontuberculous mycobacteria (NTM)